Lack of association between either outpatient or inpatient glycemic control and COVID-19 illness severity or mortality in patients with diabetes
Introduction To evaluate whether outpatient insulin treatment, hemoglobin A1c (HbA1c), glucose on admission, or glycemic control during hospitalization is associated with SARS-CoV-2 (COVID-19) illness severity or mortality in hospitalized patients with diabetes mellitus (DM) in a geographical region...
Saved in:
| Main Authors: | Michael A Kohn, Paras B Mehta, Suneil K Koliwad, Robert J Rushakoff |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2021-03-01
|
| Series: | BMJ Open Diabetes Research & Care |
| Online Access: | https://drc.bmj.com/content/9/1/e002203.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pharmacoeconomic analysis of using benralizumab for treatment of severe asthma in inpatient and outpatient settings
by: M. V. Zhuravleva, et al.
Published: (2022-07-01) -
Association between glycemic variability and mortality in critically ill patients with heart failure
by: Pengcheng Liu, et al.
Published: (2025-08-01) -
Parenteral Nutrition-Associated Hyperglycemia in Noncritically Ill Inpatients Is Associated with Higher Mortality
by: Sofia Sarkisian, et al.
Published: (2010-01-01) -
Imaging and diagnostic accuracy of outpatient and inpatient hysteroscopy
by: Yu. S. Frolova, et al.
Published: (2021-12-01) -
Differentiated approach to glycemic management in type 2 diabetic patients during inpatient treatment of acute myocardial infarction: glycemic control and long-term prognosis
by: M. A. Korotina, et al.
Published: (2023-12-01)